Eastern Shore Physicians & Surgeons,inc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 9524 Hospital Ave, Nassawadox, VA 23413 Phone: 757-442-6600 |
Shore Gastroenterology Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 9524 Hospital Avenue, Nassawadox, VA 23413 Phone: 757-414-8054 |
Riverside Shore Physicians Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9507 Hospital Ave, Nassawadox, VA 23413 Phone: 757-414-8054 Fax: 757-414-8055 |
Family Practice Associates Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9506 Hospital Avenue, Nassawadox, VA 23413 Phone: 757-442-6242 Fax: 757-442-6590 |
Riverside Eastern Shore Physicians And Surgeons Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9524 Hospital Ave, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
Riverside Shore Diabetes Center General Practice Medicare: Not Enrolled in Medicare Practice Location: 9507 Hospital Ave, Nassawadox, VA 23413 Phone: 757-414-8054 |
News Archive
How do you prepare for one of the most destructive hurricanes to ever strike the United States? Fifty-two inches of rain in just three days? It's not easy but that's the job of Robert Emery, Dr.P.H., the vice president for safety, health, environment and risk management at The University of Texas Health Science Center at Houston.
With the support of a new $3 million, five-year National Institute on Aging grant, researchers from the Regenstrief Institute and Indiana University Center for Aging Research are conducting the first evaluation of the benefits and harms of Alzheimer's disease screening for family members of older adults.
Researchers at the University of Delaware have discovered a novel technique - that acts like a "spell-checker" for correcting a misspelling in the DNA code - to repair the defective gene that causes spinal muscular atrophy (SMA).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
GOP members of the Senate Finance Committee say they want more information from the Department of Health and Human Services, even as House and Senate GOP lawmakers pressed for details about the contractors who will set up insurance markets in states that don't do it themselves.
› Verified 5 days ago